Focalyx Technologies

Focalyx Technologies is a private U.S. medical device company focused on image-guided diagnosis and minimally invasive treatment of prostate cancer. Its core product, Focalyx Fusion, is an FDA-cleared software as a medical device that fuses MRI and ultrasound images to support targeted biopsy, treatment planning, and real-time procedural guidance. The company positions its approach around focal therapy that treats cancerous lesions while sparing healthy prostate tissue in order to preserve urinary and sexual function. Focalyx also markets a broader prostate-care methodology under the Focalyx brand and has collaborated with Clinical Laserthermia Systems to pair its fusion-guidance platform with focal laser ablation workflows. The company appears to operate commercially rather than as a drug developer, with its principal focus on medtech and office-based urologic procedures.